NEJM on X: "In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months
Biology | Free Full-Text | Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
survival - Time to event analysis - median (IQR) is <75% experience event - Cross Validated
Median overall survival (mOS) and median progression-free survival... | Download Scientific Diagram
Ambiguities in computing the median survival time. - FAQ 44 - GraphPad
Efficacy Data | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Efficacy Results | ONIVYDE® (irinotecan liposome injection) | HCP | Onivyde
Cureus | A Survival Analysis of Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy: A Single Center Experience | Article
Median Survival Time - an overview | ScienceDirect Topics
Median overall survival of the patients following all o | Open-i
Survival Analysis in R
Prognostic Factors for Gastric Cancer Patients With One Stage IV Factor who Underwent Conversion Surgery | Anticancer Research
Survival (time to event) data: median survival times | The BMJ
Metastasectomy and Targeted Therapy for Patients With Spinal Metastases of Renal Cell Carcinoma | International Journal of Spine Surgery
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times - interpret - Datamethods Discussion Forum
Kaplan–Meier survival curves. (A) Median overall survival was... | Download Scientific Diagram
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
Overall survival curve. Median overall survival time was 8.2 months.... | Download Scientific Diagram
Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis | SpringerLink
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
Early Clinical Data Suggests Nearly 2X Prolonged Median Survival for Inoperable, Locally Advanced Pancreatic Cancer with
Kaplan-Meier curves for overall survival. The median overall survival... | Download Scientific Diagram
MARGENZA® Clinical Results
Cancers | Free Full-Text | Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience
Kaplan-Meier survival analysis
GraphPad Prism 10 Statistics Guide - Determining the median followup time
NEJM on X: "Nivolumab increases median overall survival by 5.4 months in adv renal cell cancer. #ECC2015 http://t.co/9DSZcnbnAs http://t.co/22qcFuEfzN" / X
